17. Januar 2020
ARCHIMEDlife is very proud to announce the strategic alliance with amedes Holding GmbH, a leading provider in interdisciplinary and...Read more
25. September 2019
Combining high-quality biochemical testing with innovative genetic testing forms a powerful tool for personalized medicine, clinical research and diagnostics...Read more
27. August 2019
Exciting! Our booth with a brand new look and novel, innovative portfolio of diagnostic tests and services. First time...Read more
6. Juni 2019
We are happy to inform you that we have introduced a new diagnostic assay for the analysis of lysosomal...Read more
12. November 2017
You can easily subscribe to our bi-monthly ARCHIMEDlife Newsletter and read about laboratory diagnostics, research studies, scientific publications and...Read more
1. September 2017
September is Newborn Screening Awareness Month. Not only throughout this time we like to remind you, that you can...Read more
25. Juli 2017
An updated Consensus Guideline by worldwide experts is now available: See the publication of CLSI document NBS04-Ed2, Newborn Screening...Read more
5. Juli 2017
Background: Fabry disease (FD) is a rare X-linked lysosomal storage disease caused by mutations in the α-galactosidase A (GLA)...Read more
21. Juni 2017
We offer TREC (T-cell receptor excision circle) DNA testing from Dried Blood Spots to aid in screening newborns for...Read more
Started in 2013, ARCHIMEDlife is an independent highly-innovative company dedicated in providing and developing diagnostic services from Inborn Errors of Metabolism to Oncological Diseases. Our commitment is to provide better and faster high-quality laboratory tests for you and your family.
Our diagnostic laboratory is offering services from Clinical Mass Spectrometry to Next-Generation Sequencing. We have international collaborations with physicians, clinical researchers and industry specialized in personalized health care.
We are dedicated to the development of novel laboratory tests to make actionable health information accessible at the time it matters.